- USPTO Rejects Patent Claims Asserted by Magnolia Medical, Inc. against Kurin, Inc.
- Delaware Federal Court Issues a Stay Order in Patent Dispute between Magnolia Medical and Kurin, Inc.
- Kurin Launches Kurin Jet, Redefining the Blood Culture Contamination Device Market
- USPTO Agrees to Kurin’s Request to Review Validity of Magnolia Medical’s ‘483 Patent
- Kurin Receives 510k from the FDA with Indication to Reduce Blood Culture Contaminations
- Kurin Commends the CDC for Their Recent Publication on Blood Culture Contamination
- ENA Welcomes Kurin to 2023 Corporate Engagement Council
- Kurin, Inc. Announces Successful FDA Audit
- Kurin, Inc. Provides Update on Litigation Activity
- Kurin, Inc. Announces Full Scale Manufacturing of Push-button Needle
Need more information?
Click here to connect with Kurin.